Summary
To assess the sterilization efficacy of a combined Tween 80®, β-propiolactone and ultraviolet irradiation procedure applied to a FVIII preparation
to which an estimated 105.9 chimpanzee infectious doses (CID50) of hepatitis B virus had been added per ml, two chimpanzees were inoculated with
10 ml each of treated and untreated preparations. The untreated preparation, which
was obtained from donors with normal alanine aminotransferase (ALT) levels, induced
non-A, non-B hepatitis in both recipient animals, and delayed hepatitis B infection
in one of these. Neither animal receiving the treated preparation developed either
type of hepatitis. When subsequently challenged with the untreated material, both
of the latter animals developed non-A, non-B and hepatitis B infection, proving their
susceptibility to both types of infection.
It was concluded that the combined procedure inactivated an estimated 106.9 CID50 of hepatitis B virus and an unknown quantity of a non-A, non-B virus.
The finding of non-A, non-B virus infectivity in a pooled FVIII preparation despite
careful ALT screening of plasma donors emphasizes the necessity of subjecting such
preparations to sterilization procedures.
Keywords
Hepatitis B virus - Non-A, non-B hepatitis - Factor VIII - Virus inactivation - β-propiolactone
- Ultraviolet irradiation